Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

NCT03981575 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT03981575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03981575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Lead sponsor
Virginia Commonwealth University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2019
Completion date
December 1, 2026
Enrollment
700 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

dm1, myotonic dystrophy 1